版權說明：本文檔由用戶提供并上傳，收益歸屬內容提供方，若內容存在侵權，請進行舉報或認領
文檔簡介
急診PCI的若干問題急診PCI的若干問題Endothelialprogenitorcell(EPC)capturingstentsHighdoseGPIIb/IIIainhibitorspre-hospitalizationManualthrombusaspiration(TA)duringPPCIPredictorsofstentthrombosisafterPPCI急診PCI的若干問題Endothelialprogenitorcell(ERandomization50GenousTM50CrCo6-monthclinical,angio
&
IVUSFUGENIUS-STEMITrial2007.8-9,SinglecenterprospectiveASA100mg/day
+
clopidogrel75mg/day30daysGPIIb/IIIainhibitorsandthromboaspirationatthediscretionofthephysicianPresentedbyDr.PavelCervinkaatACC.09/i2,Orlando,FLRandomization50GenousTM50CrCGENIUS-STEMITrial6-monthclinicaloutcomeMACECVDeathsMITLRSTP=0.03P=NSP=0.04P=NSP=NSGenousTMCrCo2410PresentedbyDr.PavelCervinkaatACC.09/i2,Orlando,FLGENIUS-STEMITrialMACE
GENIUS-STEMITrialConclusionsTheuseofEPCcapturestentsinthesettingofSTEMIisfeasible
&
safe.RateofMACEat6-monthFUwassignificantlyhigherinGenousTMgroupthanCrCostents.WarrisomeistherateoflatestentthrombosisinEPCscapturestentgroup.Largerrandomizedtrialsaremandatory.PresentedbyDr.PavelCervinkaatACC.09/i2,Orlando,FLGENIUS-STEMITrialTheuseof直接PCI患者院前與導管室應用大劑量替羅非班的比較ON-TIME-2研究AGIR-2研究直接PCI患者院前與導管室應用Prospective,multicentre,placebo-controlled,randomisedSTEMI30min-24hrs5000UFH,500mgASA,600mgClopidogrelAngiogramTirofiban*PlaceboTransportationPCIcentreAngiogramTirofibanprovisionalTirofibancont’dON-TIME-2oneyrfollow-up
n=9842006.6-2007.11PPCI*Bolus:25μg/kg&0.15μg/kg/mininfusionFollow-upON-TIME-2ChristianW.Hammetal.Prospective,multicentre,placConclusionsHighdosetirofibanontopofclopidogrel(600mg)intheprehospitalsettingissafePre-Hospitalinitiationoftirofiban(HDB)improvesSTresolutionbefore&afterprimaryPCINoincreaseinbleedingriskImprovesoutcomeofprimaryPCIforAMIStrongtrendtoreducedmortalitycontinuesover1yearfollow-upInpatientsundergoingprimaryPCImortalityissignificantlylower.Highestefficacyinelderly(>65yrs),inKillipclass2andinearlypresenters.ON-TIME-2ChristianW.Hammetal.ConclusionsHighdosetirofibanMICUPatient
callSTEMIundergoingprimaryPCISTEMI20min-12h600mgclopidogrel250mgaspirinUFH60U/kgTirofiban
25μg/kgbolus,0.15ug/kgivgttAngiographyAngiographyPre-hospitalMICU
transportationCathlabRandomize
OpenLabelMedical
DispatcherTirofiban
25μg/kgbolus,0.15ug/kgivgttAGIR2(n=156)(n=156)PPCIEricBonnefoyetal.MICUPatient
callSTEMIundergoi0.61.20123456DeathSevereBleedingAcutestentthrombosisStrokeCathlabtirofibanPre-Hospitaltirofiban%p=NSp=NSp=NSp=NSIn-hospitaleventsP=NSOnadmission
toCathlabP=NSP=NSInitialTIMIgrade2-3STsegmentresolution>70%39.744.298.1978.715.255.452.6020406080100120%FinalTIMIgrade2-3P=NSCathlabtirofibanPre-hospitaltirofibanSurrogatesofreperfusionOnehr
afterPCIAGIR2ResultsandConclusionTheresultsdonotsupportthenecessitytoinitiatetirofibanadministrationinpre-hospitalsettingsEricBonnefoyetal.0.61.2012345急診PCI血栓抽吸裝置的應用
Manualthrombusaspiration(TA)duringPPCIErythrocyte-richthrombiPlatelet/fibrin-richthrombiCombinedthrombiEdematouscomponentsAtheroscleroticcomponents45231454FreshFormalinfixedFormalinfixedHEHEYANhongbingetal.急診PCI血栓抽吸裝置的應用
ManualthrombusTAPASand1-yearfollow-up0%1%2%3%4%5%6%7%8%AllcausemortalityCardiacdeathReinfarctionTAPAS1-yearfollow-upP=0.04P=0.02P=0.05AspConAspConAspConpatient0%20%40%60%80%100%45.717.126.3AspConMBG0-1MBG2MBG3MyocardialBlushGradeP＜0.00156.630.812.644.237.917.90%20%40%60%80%100%STR＜30%STR30-70%MBG＞70%AspConResolutionofST-segmentElevationP＜0.001VlaarP,etal.Lancet2008;371:1915-20;SvilaasT,etal.NEnglJ2008;358:557-676FExportaspirationcatheterintention-to-treattrialRoutineutilizationofTAn=535forTAn=536forconventionalPPCIFollow-upfor1yrTAPASand1-yearfollow-up4.77mortalityAmeta-analysisofadjunctivethrombectomyandembolicprotectiondevicesinSTEMI1996-200830randomizedtrialsn=6415patients＜12hnativevesselSTEMIEndpoints:
AllcausemortalityMACEStrokeBavryAA.etal.,EuropeanHeartJ.2008;29:2989–30016month5month4month13trialsn=30265trialsn=93412trialsn=2442mortalityAmeta-analysisofad＜12hSTEMITIMI0-1n=49successfulaspirationwithvisiblematerialDIVERCEandZEEKYANhongbingetal.0.590.520.480.50.520.540.560.580.6146257.9050100150200250300PresenceofplaquematerialPresenceofthrombusonlyPresenceofplaquematerialPresenceofthrombusonlyLVEF16hrpost-proceduralP＜0.02P＜0.02PeakCK-MBpost-proceduraln=28n=28n=21n=28n=21PlaquematerialRemovingplaquematerialsfromtheculpritlesionis
beneficialShouldTAberoutinelyperformedinTIMI2-3patients?Needstrials＜12hSTEMIYANhongbingetalArethereanydifferencesofdevicesoperabilityandclinicalimpactsamongdifferenttypeaspirationcatheters?YANhongbingetal.ChinMedJ2009;122(6):648-654SizedistributionofthrombiP=0.02forsmall,P=0.09formoderateandP=0.03forlargethrombi.
largesmallmoderateFrequencyofdual-wiresArethereanydifferencesofdClinicalimpactsofDiverCEvsZEEKYANhongbingetal.ChinMedJ2009;122(6):648-654ClinicalimpactsofDiverCEvAMI直接PCI支架血栓的預測因素：
HORIZONS-AMI試驗AMI直接PCI支架血栓的預測因素：
HORIZONS-AMNolimitationsfordrug-elutingstentsinSTEMIpatients1yr
EndpointsDESTaxus,n=2257(%)BMSExpress,n=749(%)Hazardratio(95%CI)Ischemictargetlesionrevascularization9(0.43–0.83)SafetyMACE8.18.01.02(0.76–1.36)All-causemortality9(0.64–1.55)MI1(0.54–3.22)Stroke1.00.71.52(0.58–4.00)Stentthrombosis2(0.58–1.45)Binaryrestenosis,perlesion,at13mo10.022.90.44(0.33–0.57)TCT2008:TranscatheterCardiovascularTherapeutics20thAnnualScientificSymposiumOctober12-17,2008,Washington,DCEndpointsNolimitationsfordrug-elutinIndependentPredictorsofST(CoxModel)AcuteSTSubacuteSTLateSTIndependentPredictorsofST(ConclusionsAcute,subacute&lateSTappeartoberelatedtodifferentfactorsthemostimportantpredictorsofacute&subacuteSTevents:Pharmacologicaltherapy,vesselflow,lesioncharacteristics&number&lengthofstentsthemostimportantpredictorsoflateSTevents:Patientrelatedfactorsincludingcigarettesmoking&priorMIThetypeofstentimplanted(DESvs.BMS)wasnotrelatedtoSTduringanytimeintervalupto1-yearSTwithin1-yearoccurredwithsimilarfrequencyinpatientstreatedwithUFH+GPI&bivalirudinaloneHowever,acuteSTwasmorecommonwithbivalirudin,especiallywithinthe1st5hours,whereasSTtendedtobelesscommonwithbivalirudinthanwithUFH+GPIbetween24hours&1-yearConclusionsAcute,subacute&lThankyou!Thankyou!GENIUS-STEMI
Trial6monthangio&IVUSdata
Genous
Cr-Co
PvalueANGIODATA
N=44N=47Latelumenloss(mm)0.89±0.590.79±0.47NSRestenosis(>50%)2013NS
(QCA:PieMedicalIm)IVUSN=41N=42meanin-stentNIH(mm3)49.7±48
40.0±22.8NS
(Volcano,pullback0.5%mm/s)(QIVAPieMedicalIm)
NIH:NeointimalhyperplasiainsidethestentGENIUS-STEMITrial急診PCI的若干問題急診PCI的若干問題Endothelialprogenitorcell(EPC)capturingstentsHighdoseGPIIb/IIIainhibitorspre-hospitalizationManualthrombusaspiration(TA)duringPPCIPredictorsofstentthrombosisafterPPCI急診PCI的若干問題Endothelialprogenitorcell(ERandomization50GenousTM50CrCo6-monthclinical,angio
&
IVUSFUGENIUS-STEMITrial2007.8-9,SinglecenterprospectiveASA100mg/day
+
clopidogrel75mg/day30daysGPIIb/IIIainhibitorsandthromboaspirationatthediscretionofthephysicianPresentedbyDr.PavelCervinkaatACC.09/i2,Orlando,FLRandomization50GenousTM50CrCGENIUS-STEMITrial6-monthclinicaloutcomeMACECVDeathsMITLRSTP=0.03P=NSP=0.04P=NSP=NSGenousTMCrCo2410PresentedbyDr.PavelCervinkaatACC.09/i2,Orlando,FLGENIUS-STEMITrialMACE
GENIUS-STEMITrialConclusionsTheuseofEPCcapturestentsinthesettingofSTEMIisfeasible
&
safe.RateofMACEat6-monthFUwassignificantlyhigherinGenousTMgroupthanCrCostents.WarrisomeistherateoflatestentthrombosisinEPCscapturestentgroup.Largerrandomizedtrialsaremandatory.PresentedbyDr.PavelCervinkaatACC.09/i2,Orlando,FLGENIUS-STEMITrialTheuseof直接PCI患者院前與導管室應用大劑量替羅非班的比較ON-TIME-2研究AGIR-2研究直接PCI患者院前與導管室應用Prospective,multicentre,placebo-controlled,randomisedSTEMI30min-24hrs5000UFH,500mgASA,600mgClopidogrelAngiogramTirofiban*PlaceboTransportationPCIcentreAngiogramTirofibanprovisionalTirofibancont’dON-TIME-2oneyrfollow-up
n=9842006.6-2007.11PPCI*Bolus:25μg/kg&0.15μg/kg/mininfusionFollow-upON-TIME-2ChristianW.Hammetal.Prospective,multicentre,placConclusionsHighdosetirofibanontopofclopidogrel(600mg)intheprehospitalsettingissafePre-Hospitalinitiationoftirofiban(HDB)improvesSTresolutionbefore&afterprimaryPCINoincreaseinbleedingriskImprovesoutcomeofprimaryPCIforAMIStrongtrendtoreducedmortalitycontinuesover1yearfollow-upInpatientsundergoingprimaryPCImortalityissignificantlylower.Highestefficacyinelderly(>65yrs),inKillipclass2andinearlypresenters.ON-TIME-2ChristianW.Hammetal.ConclusionsHighdosetirofibanMICUPatient
callSTEMIundergoingprimaryPCISTEMI20min-12h600mgclopidogrel250mgaspirinUFH60U/kgTirofiban
25μg/kgbolus,0.15ug/kgivgttAngiographyAngiographyPre-hospitalMICU
transportationCathlabRandomize
OpenLabelMedical
DispatcherTirofiban
25μg/kgbolus,0.15ug/kgivgttAGIR2(n=156)(n=156)PPCIEricBonnefoyetal.MICUPatient
callSTEMIundergoi0.61.20123456DeathSevereBleedingAcutestentthrombosisStrokeCathlabtirofibanPre-Hospitaltirofiban%p=NSp=NSp=NSp=NSIn-hospitaleventsP=NSOnadmission
toCathlabP=NSP=NSInitialTIMIgrade2-3STsegmentresolution>70%39.744.298.1978.715.255.452.6020406080100120%FinalTIMIgrade2-3P=NSCathlabtirofibanPre-hospitaltirofibanSurrogatesofreperfusionOnehr
afterPCIAGIR2ResultsandConclusionTheresultsdonotsupportthenecessitytoinitiatetirofibanadministrationinpre-hospitalsettingsEricBonnefoyetal.0.61.2012345急診PCI血栓抽吸裝置的應用
Manualthrombusaspiration(TA)duringPPCIErythrocyte-richthrombiPlatelet/fibrin-richthrombiCombinedthrombiEdematouscomponentsAtheroscleroticcomponents45231454FreshFormalinfixedFormalinfixedHEHEYANhongbingetal.急診PCI血栓抽吸裝置的應用
ManualthrombusTAPASand1-yearfollow-up0%1%2%3%4%5%6%7%8%AllcausemortalityCardiacdeathReinfarctionTAPAS1-yearfollow-upP=0.04P=0.02P=0.05AspConAspConAspConpatient0%20%40%60%80%100%45.717.126.3AspConMBG0-1MBG2MBG3MyocardialBlushGradeP＜0.00156.630.812.644.237.917.90%20%40%60%80%100%STR＜30%STR30-70%MBG＞70%AspConResolutionofST-segmentElevationP＜0.001VlaarP,etal.Lancet2008;371:1915-20;SvilaasT,etal.NEnglJ2008;358:557-676FExportaspirationcatheterintention-to-treattrialRoutineutilizationofTAn=535forTAn=536forconventionalPPCIFollow-upfor1yrTAPASand1-yearfollow-up4.77mortalityAmeta-analysisofadjunctivethrombectomyandembolicprotectiondevicesinSTEMI1996-200830randomizedtrialsn=6415patients＜12hnativevesselSTEMIEndpoints:
AllcausemortalityMACEStrokeBavryAA.etal.,EuropeanHeartJ.2008;29:2989–30016month5month4month13trialsn=30265trialsn=93412trialsn=2442mortalityAmeta-analysisofad＜12hSTEMITIMI0-1n=49successfulaspirationwithvisiblematerialDIVERCEandZEEKYANhongbingetal.0.590.520.480.50.520.540.560.580.6146257.9050100150200250300PresenceofplaquematerialPresenceofthrombusonlyPresenceofplaquematerialPresenceofthrombusonlyLVEF16hrpost-proceduralP＜0.02P＜0.02PeakCK-MBpost-proceduraln=28n=28n=21n=28n=21PlaquematerialRemovingplaquematerialsfromtheculpritlesionis
beneficialShouldTAberoutinelyperformedinTIMI2-3patients?Needstrials＜12hSTEMIYANhongbingetalArethereanydifferencesofdevicesoperabilityandclinicalimpactsamongdifferenttypeaspirationcatheters?YANhongbingetal.ChinMedJ2009;122(6):648-654SizedistributionofthrombiP=0.02forsmall,P=0.09formoderateandP=0.03forlargethrombi.
largesmallmoderateFrequencyofdual-wiresArethereanydifferencesofdClinicalimpactsofDiverCEvsZEEKYANhongbingetal.ChinMedJ2009;122(6):648-654ClinicalimpactsofDiverCEvAMI直接PCI支架血栓的預測因素：
HORIZONS-AMI試驗AMI直接PCI支架血栓的預測因素：
HORIZONS-AMNolimitationsfordrug-elutingstentsinSTEMIpatients1yr
EndpointsDESTaxus,n=2257(%)BMSExpress,n=749(%)Hazardratio(95%CI)Ischemictargetlesionrevascularization9(0.43–0.83)SafetyMACE8.18.01.02(0.76–1.36)All-causemortality9(0.64–1.55)MI1(0.54–3.22)Stroke1.00.71.52(0.58–4.00)Stentthrombosis2(0.58–1.45)Binaryrestenosis,perlesion,at13mo10.022.90.44(0.33–0.57)TCT2008:TranscatheterCardiovascularTherapeutics20thAnnualScientificSymposiumOctober12-17,2008,Washington,DCEndpointsNolimitationsfordrug-elutinIndependentPredictorsofST(CoxModel)AcuteSTSubacuteSTLateSTIndependentPredictorsofST(ConclusionsAcute,subacute&lateSTappear
溫馨提示
- 1. 本站所有資源如無特殊說明，都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等，如果需要附件，請聯系上傳者。文件的所有權益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙，網頁內容里面會有圖紙預覽，若沒有圖紙預覽就沒有圖紙。
- 4. 未經權益所有人同意不得將文件中的內容挪作商業(yè)或盈利用途。
- 5. 人人文庫網僅提供信息存儲空間，僅對用戶上傳內容的表現方式做保護處理，對用戶上傳分享的文檔內容本身不做任何修改或編輯，并不能對任何下載內容負責。
- 6. 下載文件中如有侵權或不適當內容，請與我們聯系，我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 手工泥巴制作課程設計
- 室外景觀設計師的植物配置與環(huán)境打造
- 保健品行業(yè)話務員工作總結
- 2025年中考物理一輪復習之物態(tài)變化
- 超市行業(yè)客服工作總結周到服務增添購物樂趣
- 化妝護膚行業(yè)銷售工作總結
- 餐飲服務員工作總結熱情招待細心服務顧客
- 【八年級下冊地理湘教版】專項02 港、澳、臺的經濟發(fā)展
- 2024年熱鬧的元宵節(jié)教案
- 2024年石家莊理工職業(yè)學院單招職業(yè)技能測試題庫標準卷
- 雨雪天氣安全教育PPT
- 深基坑支護專項施工方案(咬合樁)
- 勞務派遣服務外包技術方案
- 采購管理實務全套教學課件
- 極致物業(yè)管理系統(tǒng)收費管理業(yè)務操作
- GB∕T 29639-2020 生產經營單位生產安全事故應急預案編制導則
- 貴州省工傷保險待遇申領授權委托書
- 媒介融合(ppt)課件
- 液壓系統(tǒng)中油管尺寸的選擇
- 視頻監(jiān)控臺賬參考模板
- 初一初三國家體育鍛煉標準評分表
評論
0/150
提交評論